| 摘要 |
<p num="1"><br/><br/><br/>The invention relates to a new crystalline form II of N-benzoyl-staurosporine; <br/>compositions containing the same; processes for the preparation thereof; and <br/>the use of crystalline form II of of N-benzoyl-staurosporine in diagnostic <br/>methods or therapeutic treatment of warm-blooded animals, especially humans. <br/>The invention relates to the amorphous forms of N-benzoyl-staurosporine; <br/>compositions containing the same; processes for the preparation thereof; and <br/>the use of amorphous N-benzoyl-staurosporine in diagnostic methods or <br/>therapeutic treatment of warm-blooded animals, especially humans.<br/>
|
